
PMID- 34913151
OWN - NLM
STAT- MEDLINE
DCOM- 20220303
LR  - 20220716
IS  - 1672-0415 (Print)
IS  - 1672-0415 (Linking)
VI  - 28
IP  - 3
DP  - 2022 Mar
TI  - In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2
      Using Molecular Docking Simulation.
PG  - 249-256
LID - 10.1007/s11655-021-3504-5 [doi]
AB  - OBJECTIVE: To explore potential natural products against severe acute respiratory
      syndrome coronavirus (SARS-CoV-2) via the study of structural and non-structural 
      proteins of human coronaviruses. METHODS: In this study, we performed an
      in-silico survey of 25 potential natural compounds acting against SARS-CoV-2.
      Molecular docking studies were carried out using compounds against
      3-chymotrypsin-like protease (3CL(PRO)), papain-like protease (PL(PRO)),
      RNA-dependent RNA polymerase (RdRp), non-structural protein (nsp), human
      angiotensin converting enzyme 2 receptor (hACE2R), spike glycoprotein (S
      protein), abelson murine leukemia viral oncogene homolog 1 (ABL1),
      calcineurin-nuclear factor of activated T-cells (NFAT) and transmembrane protease
      serine 2. RESULTS: Among the screened compounds, amentoflavone showed the best
      binding affinity with the 3CL(PRO), RdRp, nsp13, nsp15, hACE2R. ABL1 and
      calcineurin-NFAT; berbamine with hACE2R and ABL1; cepharanthine with nsp10,
      nsp14, nsp16, S protein and ABL1; glucogallin with nsp15; and papyriflavonol A
      with PL(PRO) protein. Other good interacting compounds were juglanin, betulinic
      acid, betulonic acid, broussooflavan A, tomentin A, B and E,
      7-methoxycryptopleurine, aloe emodin, quercetin, tanshinone I, tylophorine and
      furruginol, which also showed excellent binding affinity towards a number of
      target proteins. Most of these compounds showed better binding affinities towards
      the target proteins than the standard drugs used in this study. CONCLUSION:
      Natural products or their derivatives may be one of the potential targets to
      fight against SARS-CoV-2.
CI  - (c) 2021. The Chinese Journal of Integrated Traditional and Western Medicine
      Press and Springer-Verlag GmbH Germany, part of Springer Nature.
FAU - Hossain, Rajib
AU  - Hossain R
AD  - Department of Pharmacy, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman
      Science and Technology University, Gopalganj, 8100, Bangladesh.
FAU - Sarkar, Chandan
AU  - Sarkar C
AD  - Department of Pharmacy, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman
      Science and Technology University, Gopalganj, 8100, Bangladesh.
FAU - Hassan, Shardar Mohammad Hafiz
AU  - Hassan SMH
AD  - Department of Pharmacy, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman
      Science and Technology University, Gopalganj, 8100, Bangladesh.
FAU - Khan, Rasel Ahmed
AU  - Khan RA
AD  - Harmacy Discipline, Life Science School, Khulna University, Khulna, 9280,
      Bangladesh.
FAU - Arman, Mohammad
AU  - Arman M
AD  - Department of Pharmacy, International Islamic University, Chittagong, Bangladesh.
FAU - Ray, Pranta
AU  - Ray P
AD  - Department of Biomedical Engineering, Huazhong University of Science and
      Technology, Wuhan, 430074, China.
FAU - Islam, Muhammad Torequl
AU  - Islam MT
AD  - Department of Pharmacy, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman
      Science and Technology University, Gopalganj, 8100, Bangladesh.
FAU - Dastan, Sevgi Durna
AU  - Dastan SD
AD  - Department of Biology, Faculty of Science, Sivas Cumhuriyet University, Sivas,
      58140, Turkey.
AD  - Beekeeping Development Application and Research Center, Sivas Cumhuriyet
      University, Sivas, 58140, Turkey.
FAU - Sharifi-Rad, Javad
AU  - Sharifi-Rad J
AD  - School of Medicine, University of Azuay, Cuenca, Ecuador.
      javad.sharifirad@gmail.com.
FAU - Almarhoon, Zainab M
AU  - Almarhoon ZM
AD  - Department of Chemistry, College of Science, King Saud University, Riyadh, 11451,
      Saudi Arabia.
FAU - Martorell, Miquel
AU  - Martorell M
AD  - Department of Nutrition and Dietetics, Faculty of Pharmacy, and Centre for
      Healthy Living, University of Concepcion, Concepcion, 4070386, Chile.
FAU - Setzer, William N
AU  - Setzer WN
AD  - Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL,
      35899, USA.
AD  - Aromatic Plant Research Center, 230 N 1200 E, Suite 100, Lehi, UT, 84043, USA.
FAU - Calina, Daniela
AU  - Calina D
AD  - Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 
      Craiova, 200349, Romania.
LA  - eng
PT  - Journal Article
DEP - 20211215
PL  - China
TA  - Chin J Integr Med
JT  - Chinese journal of integrative medicine
JID - 101181180
RN  - 0 (Antiviral Agents)
RN  - 0 (Biological Products)
SB  - IM
MH  - Animals
MH  - Antiviral Agents/pharmacology/therapeutic use
MH  - *Biological Products/pharmacology
MH  - *COVID-19/drug therapy
MH  - Humans
MH  - Mice
MH  - Molecular Docking Simulation
MH  - SARS-CoV-2
PMC - PMC8672856
OTO - NOTNLM
OT  - SARS-CoV-2
OT  - molecular docking
OT  - natural products-derived anti-SARS-CoV-2 candidates
OT  - nonstructural proteins
OT  - structural proteins
EDAT- 2021/12/17 06:00
MHDA- 2022/03/04 06:00
CRDT- 2021/12/16 06:42
PHST- 2021/01/13 00:00 [accepted]
PHST- 2021/12/17 06:00 [pubmed]
PHST- 2022/03/04 06:00 [medline]
PHST- 2021/12/16 06:42 [entrez]
AID - 10.1007/s11655-021-3504-5 [doi]
AID - 10.1007/s11655-021-3504-5 [pii]
PST - ppublish
SO  - Chin J Integr Med. 2022 Mar;28(3):249-256. doi: 10.1007/s11655-021-3504-5. Epub
      2021 Dec 15.

PMID- 34761004
OWN - NLM
STAT- MEDLINE
DCOM- 20220125
LR  - 20220125
IS  - 2314-6141 (Electronic)
VI  - 2021
DP  - 2021
TI  - Cytotoxic and Antifungal Amides Derived from Ferulic Acid: Molecular Docking and 
      Mechanism of Action.
PG  - 3598000
LID - 10.1155/2021/3598000 [doi]
AB  - Amides derived from ferulic acid have a wide spectrum of pharmacological
      activities, including antitumor and antifungal activity. In the present study, a 
      series of ten amides were obtained by coupling reactions using the reagents
      (benzotriazol-1-yloxy) tripyrrolidinophosphonium hexafluorophosphate (PyBOP) and 
      N,N'-dicyclohexylcarbodiimide (DCC). All the compounds were identified on the
      basis of their IR, (1)H- and (13)C-NMR, HRMS data, and with yields ranging from
      43.17% to 91.37%. The compounds were subjected to cytotoxic tests by the alamar
      blue technique and antifungal screening by the broth microdilution method to
      determine the minimum inhibitory concentration (MIC). The amides 10 and 11
      displayed the best result in both biological evaluations, and compound 10 was the
      most potent and selective in HL-60 cancer cells, with no cytotoxicity on healthy 
      cells. This amide had antifungal activity in all strains and had the lowest MIC
      against Candida albicans and Candida tropicalis. The possible mechanism of
      antifungal action occurs via the fungal cell wall. Molecular modeling suggested
      that compounds 10 and 11 interact with the enzymes GWT1 and GSC1, which are
      essential for the development of C. albicans. The findings of the present study
      demonstrated that compounds 10 and 11 may be used as a platform in drug
      development in the future.
CI  - Copyright (c) 2021 Mayara Castro de Morais et al.
FAU - de Morais, Mayara Castro
AU  - de Morais MC
AUID- ORCID: https://orcid.org/0000-0001-5967-9554
AD  - Laboratory of Pharmaceutical Chemistry, Department of Pharmaceutical Sciences,
      Federal University of Paraiba, 58051-900 Joao Pessoa, PB, Brazil.
FAU - Perez-Castillo, Yunierkis
AU  - Perez-Castillo Y
AUID- ORCID: https://orcid.org/0000-0002-3710-0035
AD  - Escuela de Ciencias Fisicas y Matematicas, Universidad de Las Americas, Quito,
      Ecuador.
FAU - Silva, Valdenizia Rodrigues
AU  - Silva VR
AUID- ORCID: https://orcid.org/0000-0001-8717-0501
AD  - Instituto Goncalo Moniz, Fundacao Oswaldo Cruz (IGM-FIOCRUZ/BA), Salvador,
      40296-710 Bahia, Brazil.
FAU - Santos, Luciano de Souza
AU  - Santos LS
AUID- ORCID: https://orcid.org/0000-0002-1381-1342
AD  - Instituto Goncalo Moniz, Fundacao Oswaldo Cruz (IGM-FIOCRUZ/BA), Salvador,
      40296-710 Bahia, Brazil.
FAU - Soares, Milena Botelho Pereira
AU  - Soares MBP
AUID- ORCID: https://orcid.org/0000-0001-7549-2992
AD  - Instituto Goncalo Moniz, Fundacao Oswaldo Cruz (IGM-FIOCRUZ/BA), Salvador,
      40296-710 Bahia, Brazil.
FAU - Bezerra, Daniel Pereira
AU  - Bezerra DP
AUID- ORCID: https://orcid.org/0000-0002-6774-2063
AD  - Instituto Goncalo Moniz, Fundacao Oswaldo Cruz (IGM-FIOCRUZ/BA), Salvador,
      40296-710 Bahia, Brazil.
FAU - de Castro, Ricardo Dias
AU  - de Castro RD
AUID- ORCID: https://orcid.org/0000-0001-7986-7376
AD  - Laboratory of Experimental Pharmacology and Cell Culture, Department of Clinical 
      and Social Dentistry, Federal University of Paraiba, 58051-900, Joao Pessoa, PB, 
      Brazil.
FAU - de Sousa, Damiao Pergentino
AU  - de Sousa DP
AUID- ORCID: https://orcid.org/0000-0002-7180-4896
AD  - Laboratory of Pharmaceutical Chemistry, Department of Pharmaceutical Sciences,
      Federal University of Paraiba, 58051-900 Joao Pessoa, PB, Brazil.
LA  - eng
PT  - Journal Article
DEP - 20211101
PL  - United States
TA  - Biomed Res Int
JT  - BioMed research international
JID - 101600173
RN  - 0 (Amides)
RN  - 0 (Antifungal Agents)
RN  - 0 (Coumaric Acids)
RN  - 0 (Oils, Volatile)
RN  - 0 (Organophosphorus Compounds)
RN  - 0 (Triazoles)
RN  - 0 (benzotriazol-1-yloxtri (pyrrolidinol)phosphonium hexafluorophosphate)
RN  - 538-75-0 (Dicyclohexylcarbodiimide)
RN  - AVM951ZWST (ferulic acid)
SB  - IM
MH  - Amides/chemistry/pharmacology
MH  - Antifungal Agents/pharmacology
MH  - Candida/drug effects
MH  - Coumaric Acids/chemistry/*pharmacology
MH  - Dicyclohexylcarbodiimide/*chemistry/pharmacology
MH  - Inhibitory Concentration 50
MH  - Microbial Sensitivity Tests
MH  - Molecular Docking Simulation
MH  - Oils, Volatile/chemistry
MH  - Organophosphorus Compounds/*chemistry/pharmacology
MH  - Triazoles/*chemistry/pharmacology
PMC - PMC8575619
COIS- The authors declare no conflicts of interest.
EDAT- 2021/11/12 06:00
MHDA- 2022/01/27 06:00
CRDT- 2021/11/11 07:02
PHST- 2021/06/20 00:00 [received]
PHST- 2021/09/30 00:00 [revised]
PHST- 2021/10/15 00:00 [accepted]
PHST- 2021/11/11 07:02 [entrez]
PHST- 2021/11/12 06:00 [pubmed]
PHST- 2022/01/27 06:00 [medline]
AID - 10.1155/2021/3598000 [doi]
PST - epublish
SO  - Biomed Res Int. 2021 Nov 1;2021:3598000. doi: 10.1155/2021/3598000. eCollection
      2021.

PMID- 34688822
OWN - NLM
STAT- MEDLINE
DCOM- 20211222
LR  - 20211222
IS  - 1873-6971 (Electronic)
IS  - 0367-326X (Linking)
VI  - 155
DP  - 2021 Nov
TI  - 3beta-Palmitoyloxy-olean-12-ene analogs from Sapium lateriflorum (Euphorbiaceae):
      Their cytotoxic and anti-inflammatory properties and docking studies.
PG  - 105067
LID - S0367-326X(21)00242-2 [pii]
LID - 10.1016/j.fitote.2021.105067 [doi]
AB  - Ten compounds, including a new anti-inflammatory acyl triterpene,
      3beta-palmitoyloxy-1beta,11alpha-dihydroxy-olean-12-ene, were isolated from the
      bioactive organic extract prepared from the leaves of Sapium lateriflorum (syn:
      S. nitidum). The isolated compounds were screened for their cytotoxic activity
      against selected human cancer cell lines and did not display significant
      activity. They were also evaluated as anti-inflammatory agents in mouse models
      (TPA-induced edema in the ear and in a carrageenan-induced paw edema model). The 
      results indicated that the new compound,
      3beta-palmitoyloxy-1beta,11alpha-dihydroxy-olean-12-ene, was the compound with
      major anti-inflammatory activity similar to that of indomethacin, being the
      hydroxyl at C-11 important for the observed activity. The results of docking
      studies of the 3beta-palmitoyloxy esters of olean-12-ene with NF-kappaB and with 
      COX-2 receptors were consistent with possible molecular mechanisms of the
      anti-inflammatory activity.
CI  - Copyright (c) 2021 Elsevier B.V. All rights reserved.
FAU - Novillo, Fernando
AU  - Novillo F
AD  - Instituto de Quimica, Universidad Nacional Autonoma de Mexico, Circuito Exterior,
      Ciudad Universitaria, Coyoacan 04510, Ciudad de Mexico, Mexico; Facultad de
      Ciencias Quimicas, Universidad Central del Ecuador, Francisco Viteri s/n y Gato
      Sobral, Quito, Ecuador.
FAU - Velasco-Barrios, Estela
AU  - Velasco-Barrios E
AD  - Instituto de Quimica, Universidad Nacional Autonoma de Mexico, Circuito Exterior,
      Ciudad Universitaria, Coyoacan 04510, Ciudad de Mexico, Mexico.
FAU - Nieto-Camacho, Antonio
AU  - Nieto-Camacho A
AD  - Instituto de Quimica, Universidad Nacional Autonoma de Mexico, Circuito Exterior,
      Ciudad Universitaria, Coyoacan 04510, Ciudad de Mexico, Mexico.
FAU - Lopez-Huerta, Fabiola A
AU  - Lopez-Huerta FA
AD  - Instituto de Quimica, Universidad Nacional Autonoma de Mexico, Circuito Exterior,
      Ciudad Universitaria, Coyoacan 04510, Ciudad de Mexico, Mexico.
FAU - Mendez Cuesta, Carlos A
AU  - Mendez Cuesta CA
AD  - Departamento de Sistemas Biologicos, Universidad Autonoma Metropolitana, Unidad
      Xochimilco, Calzada del Hueso 1100, Ciudad de Mexico 04960, Mexico.
FAU - Ramirez-Apan, Maria Teresa
AU  - Ramirez-Apan MT
AD  - Instituto de Quimica, Universidad Nacional Autonoma de Mexico, Circuito Exterior,
      Ciudad Universitaria, Coyoacan 04510, Ciudad de Mexico, Mexico.
FAU - Chavez, Maria Isabel
AU  - Chavez MI
AD  - Instituto de Quimica, Universidad Nacional Autonoma de Mexico, Circuito Exterior,
      Ciudad Universitaria, Coyoacan 04510, Ciudad de Mexico, Mexico.
FAU - Martinez, Esteban M
AU  - Martinez EM
AD  - Instituto de Biologia, Universidad Nacional Autonoma de Mexico, Circuito
      Exterior, Ciudad Universitaria, Coyoacan 04510, Ciudad de Mexico, Mexico.
FAU - Hernandez-Delgado, Tzasna
AU  - Hernandez-Delgado T
AD  - Laboratorio de Bioactividad de Productos Naturales, UBIPRO, Facultad de Estudios 
      Superiores-Iztacala, Universidad Nacional Autonoma de Mexico, Av. de los Barrios 
      No. 1, Los Reyes Iztacala, Tlalnepantla 54090, Estado de Mexico, Mexico.
FAU - Espinosa-Garcia, Francisco J
AU  - Espinosa-Garcia FJ
AD  - Instituto de Investigaciones en Ecosistemas y Sustentabilidad, Universidad
      Nacional Autonoma de Mexico, Ex Hacienda de San Jose de la Huerta, 58190 Morelia,
      Michoacan, Mexico.
FAU - Delgado, Guillermo
AU  - Delgado G
AD  - Instituto de Quimica, Universidad Nacional Autonoma de Mexico, Circuito Exterior,
      Ciudad Universitaria, Coyoacan 04510, Ciudad de Mexico, Mexico. Electronic
      address: delgado@unam.mx.
LA  - eng
PT  - Journal Article
DEP - 20211022
PL  - Netherlands
TA  - Fitoterapia
JT  - Fitoterapia
JID - 16930290R
RN  - 0 (Anti-Inflammatory Agents)
RN  - 0 (Esters)
RN  - 0 (Phytochemicals)
SB  - IM
MH  - Animals
MH  - Anti-Inflammatory Agents/isolation & purification/*pharmacology
MH  - Cell Line, Tumor
MH  - Edema/chemically induced/*drug therapy
MH  - Esters/isolation & purification/*pharmacology
MH  - Humans
MH  - Mexico
MH  - Mice
MH  - Molecular Docking Simulation
MH  - Molecular Structure
MH  - Phytochemicals/isolation & purification/pharmacology
MH  - Plant Leaves/chemistry
MH  - Sapium/*chemistry
OTO - NOTNLM
OT  - 11alpha-dihydroxy-olean-12-ene
OT  - 3beta-palmitoyloxy- 1beta
OT  - Anti-inflammation
OT  - Sapium lateriflorum
OT  - Triterpenes
EDAT- 2021/10/25 06:00
MHDA- 2021/12/24 06:00
CRDT- 2021/10/24 20:35
PHST- 2021/08/27 00:00 [received]
PHST- 2021/10/18 00:00 [revised]
PHST- 2021/10/18 00:00 [accepted]
PHST- 2021/10/25 06:00 [pubmed]
PHST- 2021/12/24 06:00 [medline]
PHST- 2021/10/24 20:35 [entrez]
AID - S0367-326X(21)00242-2 [pii]
AID - 10.1016/j.fitote.2021.105067 [doi]
PST - ppublish
SO  - Fitoterapia. 2021 Nov;155:105067. doi: 10.1016/j.fitote.2021.105067. Epub 2021
      Oct 22.

PMID- 33970560
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20210706
IS  - 2192-6506 (Electronic)
IS  - 2192-6506 (Linking)
VI  - 86
IP  - 7
DP  - 2021 Jul
TI  - An Androsterone-H2 @C60 hybrid: Synthesis, Properties and Molecular Docking
      Simulations with SARS-Cov-2.
PG  - 970-971
LID - 10.1002/cplu.202100133 [doi]
AB  - Invited for this month's cover are the collaborating groups of Dr. Margarita
      Suarez at Universidad de La Habana, Cuba, and Dr. Nazario Martin at Universidad
      Complutense de Madrid, Spain, together with groups at other institutions
      worldwide. The Front Cover shows a representation of the H2 @C60 hybrid molecule 
      with a dehydroepiandrosterone moiety interacting with the active site of the SARS
      Cov-2. Read the full text of the article at 10.1002/cplu.202000770.
CI  - (c) 2021 Wiley-VCH GmbH.
FAU - Suarez, Margarita
AU  - Suarez M
AUID- ORCID: 0000-0002-3138-4364
AD  - Laboratorio de Sintesis Organica, Facultad de Quimica, Universidad de la Habana, 
      10400, La Habana, Cuba.
FAU - Makowski, Kamil
AU  - Makowski K
AUID- ORCID: 0000-0001-5806-550X
AD  - Departament of Surfactants and Nanobiotechnology, Institute for Advanced
      Chemistry of Catalonia (IQAC-CSIC), and CIBER-BBN, Barcelona, Spain.
FAU - Lemos, Reinier
AU  - Lemos R
AUID- ORCID: 0000-0001-7325-1810
AD  - Laboratorio de Sintesis Organica, Facultad de Quimica, Universidad de la Habana, 
      10400, La Habana, Cuba.
FAU - Almagro, Luis
AU  - Almagro L
AUID- ORCID: 0000-0001-5186-670X
AD  - Laboratorio de Sintesis Organica, Facultad de Quimica, Universidad de la Habana, 
      10400, La Habana, Cuba.
FAU - Rodriguez, Hortensia
AU  - Rodriguez H
AUID- ORCID: 0000-0001-6910-5685
AD  - Yachay Tech University, School of Chemical Sciences and Engineering, 100119-,
      Urququi, Ecuador.
FAU - Herranz, Maria Angeles
AU  - Herranz MA
AUID- ORCID: 0000-0001-9155-134X
AD  - Departamento de Quimica Organica, Facultad de Ciencias Quimicas, Universidad
      Complutense de Madrid, 28040-, Madrid, Spain.
FAU - Molero, Dolores
AU  - Molero D
AUID- ORCID: 0000-0001-6198-1330
AD  - CAI RMN Universidad Complutense de Madrid, 28040, Madrid, Spain.
FAU - Ortiz, Orlando
AU  - Ortiz O
AUID- ORCID: 0000-0002-6845-6851
AD  - Laboratorio de Sintesis Organica, Facultad de Quimica, Universidad de la Habana, 
      10400, La Habana, Cuba.
FAU - Maroto, Enrique
AU  - Maroto E
AUID- ORCID: 0000-0002-3485-1335
AD  - Departamento de Quimica Organica, Facultad de Ciencias Quimicas, Universidad
      Complutense de Madrid, 28040-, Madrid, Spain.
FAU - Albericio, Fernando
AU  - Albericio F
AUID- ORCID: 0000-0002-8946-0462
AD  - School of Chemistry and Physics, University of KwaZul-Natal, Durban, South
      Africa.
FAU - Murata, Yasujiro
AU  - Murata Y
AUID- ORCID: 0000-0003-0287-0299
AD  - Institute for Chemical Research, Kyoto University, Uji, Kyoto, 611-0011, Japan.
FAU - Martin, Nazario
AU  - Martin N
AUID- ORCID: 0000-0002-5355-1477
AD  - Departamento de Quimica Organica, Facultad de Ciencias Quimicas, Universidad
      Complutense de Madrid, 28040-, Madrid, Spain.
LA  - eng
PT  - Journal Article
DEP - 20210510
PL  - Germany
TA  - Chempluschem
JT  - ChemPlusChem
JID - 101580948
SB  - IM
EDAT- 2021/05/11 06:00
MHDA- 2021/05/11 06:01
CRDT- 2021/05/10 12:41
PHST- 2021/05/11 06:00 [pubmed]
PHST- 2021/05/11 06:01 [medline]
PHST- 2021/05/10 12:41 [entrez]
AID - 10.1002/cplu.202100133 [doi]
PST - ppublish
SO  - Chempluschem. 2021 Jul;86(7):970-971. doi: 10.1002/cplu.202100133. Epub 2021 May 
      10.

PMID- 33540487
OWN - NLM
STAT- MEDLINE
DCOM- 20210714
LR  - 20220716
IS  - 2192-6506 (Electronic)
IS  - 2192-6506 (Linking)
VI  - 86
IP  - 7
DP  - 2021 Jul
TI  - An Androsterone-H2 @C60 hybrid: Synthesis, Properties and Molecular Docking
      Simulations with SARS-Cov-2.
PG  - 972-981
LID - 10.1002/cplu.202000770 [doi]
AB  - We report the synthesis and characterization of a fullerene-steroid hybrid that
      contains H2 @C60 and a dehydroepiandrosterone moiety synthesized by a
      cyclopropanation reaction with 76 % yield. Theoretical calculations at the
      DFT-D3(BJ)/PBE 6-311G(d,p) level predict the most stable conformation and that
      the saturation of a double bond is the main factor causing the upfield shielding 
      of the signal appearing at -3.13 ppm, which corresponds to the H2 located inside 
      the fullerene cage. Relevant stereoelectronic parameters were also investigated
      and reinforce the idea that electronic interactions must be considered to develop
      studies on chemical-biological interactions. A molecular docking simulation
      predicted that the binding energy values for the protease-hybrid complexes were
      -9.9 kcal/mol and -13.5 kcal/mol for PL(pro) and 3CL(pro) respectively,
      indicating the potential use of the synthesized steroid-H2 @C60 as
      anti-SARS-Cov-2 agent.
CI  - (c) 2021 Wiley-VCH GmbH.
FAU - Suarez, Margarita
AU  - Suarez M
AUID- ORCID: 0000-0002-3138-4364
AD  - Laboratorio de Sintesis Organica, Facultad de Quimica, Universidad de la Habana, 
      10400, La Habana, Cuba.
FAU - Makowski, Kamil
AU  - Makowski K
AUID- ORCID: 0000-0001-5806-550X
AD  - Departament of Surfactants and Nanobiotechnology, Institute for Advanced
      Chemistry of Catalonia (IQAC-CSIC) and CIBER-BBN, Barcelona, Spain.
FAU - Lemos, Reinier
AU  - Lemos R
AUID- ORCID: 0000-0001-7325-1810
AD  - Laboratorio de Sintesis Organica, Facultad de Quimica, Universidad de la Habana, 
      10400, La Habana, Cuba.
FAU - Almagro, Luis
AU  - Almagro L
AUID- ORCID: 0000-0001-5186-670X
AD  - Laboratorio de Sintesis Organica, Facultad de Quimica, Universidad de la Habana, 
      10400, La Habana, Cuba.
FAU - Rodriguez, Hortensia
AU  - Rodriguez H
AUID- ORCID: 0000-0001-6910-5685
AD  - Yachay Tech University, School of Chemical Sciences and Engineering, 100119-,
      Urququi, Ecuador.
FAU - Herranz, Maria Angeles
AU  - Herranz MA
AUID- ORCID: 0000-0001-9155-134X
AD  - Departamento de Quimica Organica, Facultad de Ciencias Quimicas, Universidad
      Complutense de Madrid, 28040-, Madrid, Spain.
FAU - Molero, Dolores
AU  - Molero D
AUID- ORCID: 0000-0001-6198-1330
AD  - CAI RMN Universidad Complutense de Madrid 28040 Madrid (Spain).
FAU - Ortiz, Orlando
AU  - Ortiz O
AUID- ORCID: 0000-0002-6845-6851
AD  - Laboratorio de Sintesis Organica, Facultad de Quimica, Universidad de la Habana, 
      10400, La Habana, Cuba.
FAU - Maroto, Enrique
AU  - Maroto E
AUID- ORCID: 0000-0002-3485-1335
AD  - Departamento de Quimica Organica, Facultad de Ciencias Quimicas, Universidad
      Complutense de Madrid, 28040-, Madrid, Spain.
FAU - Albericio, Fernando
AU  - Albericio F
AUID- ORCID: 0000-0002-8946-0462
AD  - School of Chemistry and Physics, University of KwaZul-Natal, Durban, South
      Africa.
FAU - Murata, Yasujiro
AU  - Murata Y
AUID- ORCID: 0000-0003-0287-0299
AD  - Institute for Chemical Research, Kyoto University Uji, Kyoto, 611-0011, Japan.
FAU - Martin, Nazario
AU  - Martin N
AUID- ORCID: 0000-0002-5355-1477
AD  - Departamento de Quimica Organica, Facultad de Ciencias Quimicas, Universidad
      Complutense de Madrid, 28040-, Madrid, Spain.
LA  - eng
GR  - CTQ2017-83531-R/Ministerio de Economia y Competitividad (MINECO) of Spain
GR  - P223LH-001-059/PNCB of MES, Cuba
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20210204
PL  - Germany
TA  - Chempluschem
JT  - ChemPlusChem
JID - 101580948
RN  - 0 (Antiviral Agents)
RN  - 0 (Fullerenes)
RN  - C24W7J5D5R (Androsterone)
RN  - EC 3.4.22.- (3C-like protease, SARS coronavirus)
RN  - EC 3.4.22.2 (Coronavirus Papain-Like Proteases)
RN  - EC 3.4.22.2 (papain-like protease, SARS-CoV-2)
RN  - EC 3.4.22.28 (Coronavirus 3C Proteases)
RN  - NP9U26B839 (fullerene C60)
SB  - IM
MH  - Androsterone/*chemistry
MH  - Antiviral Agents/*chemistry/metabolism
MH  - Binding Sites
MH  - COVID-19/pathology/virology
MH  - Coronavirus 3C Proteases/chemistry/metabolism
MH  - Coronavirus Papain-Like Proteases/chemistry/metabolism
MH  - Density Functional Theory
MH  - Fullerenes/*chemistry
MH  - Humans
MH  - *Molecular Docking Simulation
MH  - Protein Binding
MH  - SARS-CoV-2/isolation & purification/*metabolism
MH  - Static Electricity
MH  - Thermodynamics
PMC - PMC8014820
OTO - NOTNLM
OT  - *SARS-Cov-2
OT  - *cyclopropanation
OT  - *fullerenes
OT  - *molecular docking
OT  - *steroid hybrids
EDAT- 2021/02/05 06:00
MHDA- 2021/07/15 06:00
CRDT- 2021/02/04 20:22
PHST- 2021/01/21 00:00 [revised]
PHST- 2020/12/02 00:00 [received]
PHST- 2021/02/05 06:00 [pubmed]
PHST- 2021/07/15 06:00 [medline]
PHST- 2021/02/04 20:22 [entrez]
AID - 10.1002/cplu.202000770 [doi]
PST - ppublish
SO  - Chempluschem. 2021 Jul;86(7):972-981. doi: 10.1002/cplu.202000770. Epub 2021 Feb 
      4.

PMID- 33241943
OWN - NLM
STAT- MEDLINE
DCOM- 20210208
LR  - 20210208
IS  - 1029-046X (Electronic)
IS  - 1026-776X (Linking)
VI  - 32
IP  - 1
DP  - 2021 Jan
TI  - QSAR and molecular docking modelling of anti-leishmanial activities of organic
      selenium and tellurium compounds.
PG  - 29-50
LID - 10.1080/1062936X.2020.1848914 [doi]
AB  - Leishmaniasis affects mainly rural areas and the poorest people in the world. A
      computational study of the antileishmanial activity of organic selenium and
      tellurium compounds was performed. The 3D structures of the compounds were
      optimized at the wb97xd/lanl2dz level and used in the quantitative
      structure-activity relationship (QSAR) analysis. The antileishmanial activity was
      measured by L. donovani beta carbonic anhydrase inhibition (Ki) and the
      half-maximal inhibitory concentration (IC50) against L. infantum amastigotes. The
      dataset was divided into training (75%) and test sets (25%) by using a k-means
      clustering algorithm. For pKi prediction, model M3 with seven 3D topographic
      descriptors was characterized by the following statistical parameters: r (2) =
      0.879, Q (2) LOO = 0.822, and Q (2) ext = 0.840. For pIC50 prediction, model M12 
      with six attributes was characterized by the following statistical parameters: r 
      (2) = 0.907, Q (2) LOO = 0.824, and Q (2) ext = 0.795. Both models met all the
      requirements of Tropsha s test, which implies predictions of pIC50 and pKi
      activities with high accuracy. Concomitantly, favourable interactions of the
      sulphonamide group with the Zn atom in the protein were revealed by the docking
      analysis.
FAU - Cabrera, N
AU  - Cabrera N
AUID- ORCID: https://orcid.org/0000-0002-9678-6823
AD  - Department of Biomedical Engineering, Texas A&M University , College Station, TX,
      USA.
FAU - Mora, J R
AU  - Mora JR
AUID- ORCID: https://orcid.org/0000-0001-6128-9504
AD  - Grupo de Quimica Computacional y Teorica (QCT-USFQ), Departamento de Ingenieria
      Quimica, Universidad San Francisco de Quito , Quito, Ecuador.
FAU - Marquez, E
AU  - Marquez E
AUID- ORCID: https://orcid.org/0000-0002-7503-1528
AD  - Grupo de Investigaciones en Quimica y Biologia, Departamento de Quimica y
      Biologia, Facultad de Ciencias Exactas, Universidad del Norte , Barranquilla,
      Colombia.
FAU - Flores-Morales, V
AU  - Flores-Morales V
AUID- ORCID: https://orcid.org/0000-0003-4540-1011
AD  - Laboratorio de Sintesis Asimetrica y Bioenergetica (LSAyB), Ingenieria Quimica
      (UACQ), Program of Doctorate in Sciences with Orientation in Molecular Medicine, 
      Academic Unit of Human Medicine and Health Sciences, Universidad Autonoma de
      Zacatecas , Zacatecas, Mexico.
FAU - Calle, L
AU  - Calle L
AD  - Instituto de Investigacion e Innovacion en Salud Integral (ISAIN), Facultad de
      Ciencias Medicas, Universidad Catolica Santiago de Guayaquil , Guayaquil,
      Ecuador.
FAU - Cortes, E
AU  - Cortes E
AD  - Grupo de Investigacion en Ciencias Naturales y Exactas, Departamento de Ciencias 
      Naturales y Exactas, Universidad de la Costa , Barranquilla, Colombia.
LA  - eng
PT  - Journal Article
DEP - 20201126
PL  - England
TA  - SAR QSAR Environ Res
JT  - SAR and QSAR in environmental research
JID - 9440156
RN  - 0 (Antiprotozoal Agents)
RN  - 0 (Selenium Compounds)
RN  - NQA0O090ZJ (Tellurium)
SB  - IM
MH  - Antiprotozoal Agents/*pharmacology
MH  - Leishmania donovani/*drug effects
MH  - Leishmania infantum/*drug effects
MH  - *Molecular Docking Simulation
MH  - *Quantitative Structure-Activity Relationship
MH  - Selenium Compounds/*pharmacology
MH  - Tellurium/*pharmacology
OTO - NOTNLM
OT  - Leishmaniasis
OT  - QSAR
OT  - docking analysis
OT  - organic selenium compounds
OT  - protozoan parasites
EDAT- 2020/11/27 06:00
MHDA- 2021/02/09 06:00
CRDT- 2020/11/26 12:06
PHST- 2020/11/27 06:00 [pubmed]
PHST- 2021/02/09 06:00 [medline]
PHST- 2020/11/26 12:06 [entrez]
AID - 10.1080/1062936X.2020.1848914 [doi]
PST - ppublish
SO  - SAR QSAR Environ Res. 2021 Jan;32(1):29-50. doi: 10.1080/1062936X.2020.1848914.
      Epub 2020 Nov 26.

PMID- 33172092
OWN - NLM
STAT- MEDLINE
DCOM- 20201204
LR  - 20201214
IS  - 1420-3049 (Electronic)
IS  - 1420-3049 (Linking)
VI  - 25
IP  - 21
DP  - 2020 Nov 6
TI  - Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible
      Inhibitors of the SARS-CoV-2 M(pro) Protease.
LID - E5172 [pii]
LID - 10.3390/molecules25215172 [doi]
AB  - Wuhan, China was the epicenter of the first zoonotic transmission of the severe
      acute respiratory syndrome coronavirus clade 2 (SARS-CoV-2) in December 2019 and 
      it is the causative agent of the novel human coronavirus disease 2019 (COVID-19).
      Almost from the beginning of the COVID-19 outbreak several attempts were made to 
      predict possible drugs capable of inhibiting the virus replication. In the
      present work a drug repurposing study is performed to identify potential
      SARS-CoV-2 protease inhibitors. We created a Quantitative Structure-Activity
      Relationship (QSAR) model based on a machine learning strategy using hundreds of 
      inhibitor molecules of the main protease (M(pro)) of the SARS-CoV coronavirus.
      The QSAR model was used for virtual screening of a large list of drugs from the
      DrugBank database. The best 20 candidates were then evaluated in-silico against
      the M(pro) of SARS-CoV-2 by using docking and molecular dynamics analyses.
      Docking was done by using the Gold software, and the free energies of binding
      were predicted with the MM-PBSA method as implemented in AMBER. Our results
      indicate that levothyroxine, amobarbital and ABP-700 are the best potential
      inhibitors of the SARS-CoV-2 virus through their binding to the M(pro) enzyme.
      Five other compounds showed also a negative but small free energy of binding:
      nikethamide, nifurtimox, rebimastat, apomine and rebastinib.
FAU - Tejera, Eduardo
AU  - Tejera E
AD  - Grupo de Bio-Quimioinformatica, Universidad de Las Americas, Quito 170513,
      Ecuador.
AD  - Facultad de Ingenieria y Ciencias Aplicadas, Universidad de Las Americas, Quito
      170513, Ecuador.
FAU - Munteanu, Cristian R
AU  - Munteanu CR
AUID- ORCID: 0000-0002-5628-2268
AD  - Faculty of Computer Science, Centre for Information and Communications Technology
      Research (CITIC), University of A Coruna, 15007 A Coruna, Spain.
AD  - Biomedical Research Institute of A Coruna (INIBIC), University Hospital Complex
      of A Coruna (CHUAC), 15006 A Coruna, Spain.
FAU - Lopez-Cortes, Andres
AU  - Lopez-Cortes A
AUID- ORCID: 0000-0003-1503-1929
AD  - Centro de Investigacion Genetica y Genomica, Facultad de Ciencias de la Salud
      Eugenio Espejo, Universidad UTE, Quito 170129, Ecuador.
AD  - Latin American Network for Implementation and Validation of Clinical
      Pharmacogenomics Guidelines (RELIVAF-CYTED), 28029 Madrid, Spain.
FAU - Cabrera-Andrade, Alejandro
AU  - Cabrera-Andrade A
AUID- ORCID: 0000-0001-9702-6618
AD  - Grupo de Bio-Quimioinformatica, Universidad de Las Americas, Quito 170513,
      Ecuador.
AD  - Carrera de Enfermeria, Facultad de Ciencias de la Salud, Universidad de Las
      Americas, Quito 170513, Ecuador.
FAU - Perez-Castillo, Yunierkis
AU  - Perez-Castillo Y
AUID- ORCID: 0000-0002-3710-0035
AD  - Grupo de Bio-Quimioinformatica, Universidad de Las Americas, Quito 170513,
      Ecuador.
AD  - Escuela de Ciencias Fisicas y Matematicas, Universidad de Las Americas, Quito
      170513, Ecuador.
LA  - eng
PT  - Journal Article
DEP - 20201106
PL  - Switzerland
TA  - Molecules
JT  - Molecules (Basel, Switzerland)
JID - 100964009
RN  - 0 (Antiviral Agents)
RN  - 0 (Protease Inhibitors)
RN  - 0 (Small Molecule Libraries)
RN  - EC 3.4.22.- (3C-like protease, SARS coronavirus)
RN  - EC 3.4.22.28 (Coronavirus 3C Proteases)
RN  - GWH6IJ239E (Amobarbital)
RN  - Q51BO43MG4 (Thyroxine)
SB  - IM
MH  - Amobarbital/pharmacology
MH  - Antiviral Agents/chemistry/*pharmacology
MH  - Binding Sites
MH  - COVID-19/*drug therapy
MH  - Computer Simulation
MH  - Coronavirus 3C Proteases/*antagonists & inhibitors
MH  - Drug Discovery/*methods
MH  - Drug Repositioning/*methods
MH  - Humans
MH  - Machine Learning
MH  - Molecular Docking Simulation
MH  - Molecular Dynamics Simulation
MH  - Pandemics
MH  - Protease Inhibitors/chemistry/*pharmacology
MH  - Protein Binding
MH  - Quantitative Structure-Activity Relationship
MH  - SARS-CoV-2/drug effects/*enzymology
MH  - Small Molecule Libraries/chemistry
MH  - Software
MH  - Thermodynamics
MH  - Thyroxine/pharmacology
PMC - PMC7664330
OTO - NOTNLM
OT  - COVID-19
OT  - QSAR
OT  - SARS-CoV-2
OT  - drugs repurposing
OT  - molecular dynamics
EDAT- 2020/11/12 06:00
MHDA- 2020/12/15 06:00
CRDT- 2020/11/11 01:02
PHST- 2020/09/26 00:00 [received]
PHST- 2020/10/28 00:00 [revised]
PHST- 2020/11/04 00:00 [accepted]
PHST- 2020/11/11 01:02 [entrez]
PHST- 2020/11/12 06:00 [pubmed]
PHST- 2020/12/15 06:00 [medline]
AID - molecules25215172 [pii]
AID - 10.3390/molecules25215172 [doi]
PST - epublish
SO  - Molecules. 2020 Nov 6;25(21). pii: molecules25215172. doi:
      10.3390/molecules25215172.

PMID- 33084512
OWN - NLM
STAT- MEDLINE
DCOM- 20220302
LR  - 20220302
IS  - 1538-0254 (Electronic)
IS  - 0739-1102 (Linking)
VI  - 40
IP  - 5
DP  - 2022 Mar
TI  - Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal
      plants of the Andean Region: molecular docking and molecular dynamics
      simulations.
PG  - 2010-2023
LID - 10.1080/07391102.2020.1835716 [doi]
AB  - Given the highly contagious nature of SARS-CoV-2, it has resulted in an
      unprecedented number of COVID-19 infected and dead people worldwide. Since there 
      is currently no vaccine available in the market, the identification of potential 
      drugs is urgently needed to control the pandemic. In this study, 92
      phytochemicals from medicinal plants growing in the Andean region were screened
      against SARS-CoV-2 3 C-like protease (3CLpro) and RNA-dependent RNA polymerase
      (RdRp) in their active sites through molecular docking. The cutoff values were
      set from the lowest docking scores of the FDA-approved drugs that are being used 
      to treat COVID-19 patients (remdesivir, lopinavir, and ritonavir). Compounds with
      docking scores that were lower than cutoff values were validated by molecular
      dynamics simulation with GROMACS, using root mean square deviation (RMSD), root
      mean square fluctuation (RMSF), radius of gyration (Rg), and intermolecular
      hydrogen bonds (H-bonds). Furthermore, binding free energies were estimated using
      the MM-PBSA method, and ADMET profiles of potential inhibitors were assessed.
      Computational analyses revealed that the interaction with hesperidin (theoretical
      binding energies, DeltaGbind = -15.18 kcal/mol to 3CLpro and DeltaGbind = -9.46
      kcal/mol to RdRp) remained stable in both enzymes, unveiling its remarkable
      potential as a possible multitarget antiviral agent to treat COVID-19.
      Importantly, lupinifolin with an estimated binding affinity to 3CLpro higher than
      hesperidin (DeltaGbind = -20.93 kcal/mol) is also a potential inhibitor of the
      3CLpro. These two compounds displayed suitable pharmacological and structural
      properties to be drug candidates, demonstrating to be worthy of further
      research.Communicated by Ramaswamy H. Sarma.
FAU - Mosquera-Yuqui, Francisco
AU  - Mosquera-Yuqui F
AD  - Departamento de Ciencias de La Vida y La Agricultura, Universidad de Las Fuerzas 
      Armadas-ESPE, Sangolqui, Ecuador.
AD  - Grupo de Investigacion y Desarrollo de la Biotecnologia BioSin-Biociencias,
      Quito, Ecuador.
FAU - Lopez-Guerra, Nicolas
AU  - Lopez-Guerra N
AD  - Grupo de Investigacion y Desarrollo de la Biotecnologia BioSin-Biociencias,
      Quito, Ecuador.
AD  - Oklahoma State University, Stillwater, OK, USA.
FAU - Moncayo-Palacio, Eduardo A
AU  - Moncayo-Palacio EA
AD  - Grupo de Investigacion y Desarrollo de la Biotecnologia BioSin-Biociencias,
      Quito, Ecuador.
AD  - Departamento de Quimica y Ciencias Exactas, Universidad Tecnica Particular de
      Loja, Loja, Ecuador.
LA  - eng
PT  - Journal Article
DEP - 20201021
PL  - England
TA  - J Biomol Struct Dyn
JT  - Journal of biomolecular structure & dynamics
JID - 8404176
RN  - 0 (Phytochemicals)
RN  - EC 2.7.7.48 (RNA-Dependent RNA Polymerase)
SB  - IM
MH  - *COVID-19/drug therapy
MH  - Humans
MH  - Molecular Docking Simulation
MH  - Molecular Dynamics Simulation
MH  - Phytochemicals/pharmacology
MH  - *Plants, Medicinal
MH  - RNA-Dependent RNA Polymerase
MH  - SARS-CoV-2
PMC - PMC7657401
OTO - NOTNLM
OT  - *ADMET
OT  - *MM-PBSA
OT  - *SARS-CoV-2
OT  - *molecular docking
OT  - *molecular dynamics
EDAT- 2020/10/22 06:00
MHDA- 2022/03/03 06:00
CRDT- 2020/10/21 12:20
PHST- 2020/10/22 06:00 [pubmed]
PHST- 2022/03/03 06:00 [medline]
PHST- 2020/10/21 12:20 [entrez]
AID - 10.1080/07391102.2020.1835716 [doi]
PST - ppublish
SO  - J Biomol Struct Dyn. 2022 Mar;40(5):2010-2023. doi:
      10.1080/07391102.2020.1835716. Epub 2020 Oct 21.

PMID- 32596343
OWN - NLM
STAT- MEDLINE
DCOM- 20210312
LR  - 20210312
IS  - 2314-6141 (Electronic)
VI  - 2020
DP  - 2020
TI  - Bioactivity and Molecular Docking Studies of Derivatives from Cinnamic and
      Benzoic Acids.
PG  - 6345429
LID - 10.1155/2020/6345429 [doi]
AB  - Over the last decade, there has been a dramatic increase in the prevalence and
      gravity of systemic fungal diseases. This study aimed therefore at evaluating the
      antifungal potential of ester derivatives of benzoic and cinnamic acids from
      three Candida species. The compounds were prepared via Fischer esterification,
      and the antifungal assay was performed by the microdilution method in 96-well
      microplates for determining the minimal inhibitory concentrations (MICs). The
      findings of the antifungal tests revealed that the analogue compound methyl
      ferulate, methyl o-coumarate, and methyl biphenyl-3-carboxylate displayed an
      interesting antifungal activity against all Candida strains tested, with MIC
      values of 31.25-62.5, 62.5-125, and 62.5 mug/ml, respectively. A preliminary
      Structure-Activity Relationship study of benzoic and cinnamic acid derivatives
      has led to the recognition of some important structural requirements for
      antifungal activity. The results of molecular docking indicate that the presence 
      of the enoate moiety along with hydroxyl and one methoxy substitution in the
      phenyl ring has a positive effect on the bioactivity of compound 7 against
      Candida albicans. These observations further support the hypothesis that the
      antifungal activity of compound 7 could be due to its binding to multiple
      targets, specifically to QR, TS, and ST-PK. Additional experiments are required
      in the future to test this hypothesis and to propose novel compounds with
      improved antifungal activity.
CI  - Copyright (c) 2020 Yunierkis Perez-Castillo et al.
FAU - Perez-Castillo, Yunierkis
AU  - Perez-Castillo Y
AUID- ORCID: https://orcid.org/0000-0002-3710-0035
AD  - Escuela de Ciencias Fisicas y Matematicas, Universidad de Las Americas, Quito,
      Ecuador.
FAU - Lima, Tamires C
AU  - Lima TC
AUID- ORCID: https://orcid.org/0000-0001-6200-649X
AD  - Department of Pharmacy, Federal University of Sergipe, CEP, 49100-000 Sao
      Cristovao, Sergipe, Brazil.
FAU - Ferreira, Alana R
AU  - Ferreira AR
AUID- ORCID: https://orcid.org/0000-0003-3140-3489
AD  - Department of Pharmaceutical Sciences, Federal University of Paraiba, CEP,
      58051-970 Joao Pessoa, Paraiba, Brazil.
FAU - Silva, Cecilia R
AU  - Silva CR
AUID- ORCID: https://orcid.org/0000-0003-4964-351X
AD  - Department of Clinical and Toxicological Analysis, School of Pharmacy, Laboratory
      for Bioprospection and Experiments in Yeast, LABEL, Federal University of Ceara, 
      Fortaleza, CE, Brazil.
FAU - Campos, Rosana S
AU  - Campos RS
AUID- ORCID: https://orcid.org/0000-0003-2616-978X
AD  - Department of Clinical and Toxicological Analysis, School of Pharmacy, Laboratory
      for Bioprospection and Experiments in Yeast, LABEL, Federal University of Ceara, 
      Fortaleza, CE, Brazil.
FAU - Neto, Joao B A
AU  - Neto JBA
AUID- ORCID: https://orcid.org/0000-0002-3180-3012
AD  - Department of Clinical and Toxicological Analysis, School of Pharmacy, Laboratory
      for Bioprospection and Experiments in Yeast, LABEL, Federal University of Ceara, 
      Fortaleza, CE, Brazil.
FAU - Magalhaes, Hemerson I F
AU  - Magalhaes HIF
AUID- ORCID: https://orcid.org/0000-0001-7139-8712
AD  - Department of Pharmaceutical Sciences, Federal University of Paraiba, CEP,
      58051-970 Joao Pessoa, Paraiba, Brazil.
FAU - Cavalcanti, Bruno C
AU  - Cavalcanti BC
AUID- ORCID: https://orcid.org/0000-0002-0725-8392
AD  - Department of Physiology and Pharmacology, Federal University of Ceara,
      Fortaleza, CE, Brazil.
FAU - Junior, Helio V N
AU  - Junior HVN
AUID- ORCID: https://orcid.org/0000-0003-0156-5882
AD  - Department of Clinical and Toxicological Analysis, School of Pharmacy, Laboratory
      for Bioprospection and Experiments in Yeast, LABEL, Federal University of Ceara, 
      Fortaleza, CE, Brazil.
FAU - de Sousa, Damiao P
AU  - de Sousa DP
AUID- ORCID: https://orcid.org/0000-0002-7180-4896
AD  - Department of Pharmaceutical Sciences, Federal University of Paraiba, CEP,
      58051-970 Joao Pessoa, Paraiba, Brazil.
LA  - eng
PT  - Journal Article
DEP - 20200521
PL  - United States
TA  - Biomed Res Int
JT  - BioMed research international
JID - 101600173
RN  - 0 (Antifungal Agents)
RN  - 0 (Benzoates)
RN  - 0 (Cinnamates)
RN  - 140-10-3 (cinnamic acid)
SB  - IM
MH  - Antifungal Agents/chemistry/*pharmacology
MH  - Benzoates/chemistry/*pharmacology
MH  - Candida/*drug effects
MH  - Cinnamates/chemistry/*pharmacology
MH  - Microbial Sensitivity Tests
MH  - Molecular Docking Simulation
MH  - Molecular Structure
MH  - Structure-Activity Relationship
PMC - PMC7273447
COIS- No potential conflict of interest was reported by the authors.
EDAT- 2020/07/01 06:00
MHDA- 2021/03/13 06:00
CRDT- 2020/06/30 06:00
PHST- 2020/02/22 00:00 [received]
PHST- 2020/04/23 00:00 [accepted]
PHST- 2020/06/30 06:00 [entrez]
PHST- 2020/07/01 06:00 [pubmed]
PHST- 2021/03/13 06:00 [medline]
AID - 10.1155/2020/6345429 [doi]
PST - epublish
SO  - Biomed Res Int. 2020 May 21;2020:6345429. doi: 10.1155/2020/6345429. eCollection 
      2020.

PMID- 31861689
OWN - NLM
STAT- MEDLINE
DCOM- 20200520
LR  - 20200520
IS  - 1420-3049 (Electronic)
IS  - 1420-3049 (Linking)
VI  - 25
IP  - 1
DP  - 2019 Dec 19
TI  - Modeling the Antileukemia Activity of Ellipticine-Related Compounds: QSAR and
      Molecular Docking Study.
LID - E24 [pii]
LID - 10.3390/molecules25010024 [doi]
AB  - The antileukemia cancer activity of organic compounds analogous to ellipticine
      representes a critical endpoint in the understanding of this dramatic disease. A 
      molecular modeling simulation on a dataset of 23 compounds, all of which comply
      with Lipinski's rules and have a structure analogous to ellipticine, was
      performed using the quantitative structure activity relationship (QSAR)
      technique, followed by a detailed docking study on three different proteins
      significantly involved in this disease (PDB IDs: SYK, PI3K and BTK). As a result,
      a model with only four descriptors (HOMO, softness, AC1RABAMBID, and TS1KFABMID) 
      was found to be robust enough for prediction of the antileukemia activity of the 
      compounds studied in this work, with an R(2) of 0.899 and Q(2) of 0.730. A
      favorable interaction between the compounds and their target proteins was found
      in all cases; in particular, compounds 9 and 22 showed high activity and binding 
      free energy values of around -10 kcal/mol. Theses compounds were evaluated in
      detail based on their molecular structure, and some modifications are suggested
      herein to enhance their biological activity. In particular, compounds 22_1, 22_2,
      9_1, and 9_2 are indicated as possible new, potent ellipticine derivatives to be 
      synthesized and biologically tested.
FAU - Marquez, Edgar
AU  - Marquez E
AD  - Grupo de Investigacion en Quimica y Biologia, Departamento de Quimica y Biologia,
      Universidad del Norte, Cra 51B, Km 5, via Puerto Colombia, Barranquilla 081007,
      Colombia.
FAU - Mora, Jose R
AU  - Mora JR
AD  - Grupo de Quimica computacional y teorica (QCT-USFQ) & instituto de Simulacion
      Computacional (ISC-USF), Departamento de Ingenieria Quimica, Colegio Politecnico 
      de Ciencias e Ingenieria, Diego de Robles, y via Interoceanica, Universidad San
      Francisco de Quito, Quito 170901, Ecuador.
FAU - Flores-Morales, Virginia
AU  - Flores-Morales V
AD  - Laboratorio de Sintesis Asimetrica y Bioenergetica (LSAyB), Ingenieria Quimica
      (UACQ), Program of Doctorate in Sciences with orientation in Molecular Medicine, 
      Academic Unit of Human Medicine and Health Sciences, Universidad Autonoma de
      Zacatecas, Campus XXI Km 6 Carr. Zac-Gdl Edificio 6, 98160 Zacatecas, Mexico.
FAU - Insuasty, Daniel
AU  - Insuasty D
AD  - Grupo de Investigacion en Quimica y Biologia, Departamento de Quimica y Biologia,
      Universidad del Norte, Cra 51B, Km 5, via Puerto Colombia, Barranquilla 081007,
      Colombia.
FAU - Calle, Luis
AU  - Calle L
AD  - Instituto de Biomedicina, Facultad de Medicina, Universidad Catolica Santiago de 
      Guayaquil, Guayaquil 09013493, Ecuador.
LA  - eng
PT  - Journal Article
DEP - 20191219
PL  - Switzerland
TA  - Molecules
JT  - Molecules (Basel, Switzerland)
JID - 100964009
RN  - 0 (Antineoplastic Agents)
RN  - 0 (Ellipticines)
RN  - EC 2.7.10.2 (Agammaglobulinaemia Tyrosine Kinase)
RN  - EC 2.7.10.2 (BTK protein, human)
RN  - EC 2.7.10.2 (SYK protein, human)
RN  - EC 2.7.10.2 (Syk Kinase)
SB  - IM
MH  - Agammaglobulinaemia Tyrosine Kinase/chemistry/metabolism
MH  - Antineoplastic Agents/*chemical synthesis/chemistry/pharmacology
MH  - Cell Line, Tumor
MH  - Density Functional Theory
MH  - Ellipticines/*chemical synthesis/chemistry/pharmacology
MH  - Humans
MH  - Leukemia/drug therapy/*metabolism
MH  - Models, Molecular
MH  - Molecular Docking Simulation
MH  - Molecular Dynamics Simulation
MH  - Molecular Structure
MH  - Phosphatidylinositol 3-Kinases/chemistry/metabolism
MH  - Quantitative Structure-Activity Relationship
MH  - Syk Kinase/chemistry/*metabolism
PMC - PMC6982814
OTO - NOTNLM
OT  - QSAR
OT  - cancer
OT  - leukemia
OT  - molecular descriptors
OT  - molecular modeling
COIS- The authors declare no conflict of interest.
EDAT- 2019/12/22 06:00
MHDA- 2020/05/21 06:00
CRDT- 2019/12/22 06:00
PHST- 2019/10/30 00:00 [received]
PHST- 2019/12/11 00:00 [revised]
PHST- 2019/12/16 00:00 [accepted]
PHST- 2019/12/22 06:00 [entrez]
PHST- 2019/12/22 06:00 [pubmed]
PHST- 2020/05/21 06:00 [medline]
AID - molecules25010024 [pii]
AID - 10.3390/molecules25010024 [doi]
PST - epublish
SO  - Molecules. 2019 Dec 19;25(1). pii: molecules25010024. doi:
      10.3390/molecules25010024.

PMID- 31449403
OWN - NLM
STAT- MEDLINE
DCOM- 20200910
LR  - 20200910
IS  - 1549-960X (Electronic)
IS  - 1549-9596 (Linking)
VI  - 59
IP  - 9
DP  - 2019 Sep 23
TI  - CompScore: Boosting Structure-Based Virtual Screening Performance by
      Incorporating Docking Scoring Function Components into Consensus Scoring.
PG  - 3655-3666
LID - 10.1021/acs.jcim.9b00343 [doi]
AB  - Consensus scoring has become a commonly used strategy within structure-based
      virtual screening (VS) workflows with improved performance compared to those
      based in a single scoring function. However, no research has been devoted to
      analyze the worth of docking scoring functions components in consensus scoring.
      We implemented and tested a method that incorporates docking scoring functions
      components into the setting of high performance VS workflows. This method uses
      genetic algorithms for finding the combination of scoring components that
      maximizes the VS enrichment for any target. Our methodology was validated using a
      data set including ligands and decoys for 102 targets that have been widely used 
      in VS validation studies. Results show that our approach outperforms other
      methods for all targets. It also boosts the initial enrichment performance of the
      traditional use of whole scoring functions in consensus scoring by an average of 
      45%. Our methodology showed to be outstandingly predictive when challenged to
      rescore external (previously unseen) data. Remarkably, CompScore was able not
      only to retain its performance after redocking with a different software, but
      also proved that the enrichment obtained was not artificial. CompScore is freely 
      available at: http://bioquimio.udla.edu.ec/compscore/ .
FAU - Perez-Castillo, Yunierkis
AU  - Perez-Castillo Y
AUID- ORCID: 0000-0002-3710-0035
AD  - Bio-Cheminformatics Research Group and Escuela de Ciencias Fisicas y Matematicas 
      , Universidad de Las Americas , Quito 170504 , Ecuador.
FAU - Sotomayor-Burneo, Stellamaris
AU  - Sotomayor-Burneo S
AD  - Departamento de Ciencias Biologicas , Universidad Tecnica Particular de Loja ,
      Loja 110107 , Ecuador.
FAU - Jimenes-Vargas, Karina
AU  - Jimenes-Vargas K
AD  - Direccion General de Investigacion , Universidad de Las Americas , Quito 170504 ,
      Ecuador.
FAU - Gonzalez-Rodriguez, Mario
AU  - Gonzalez-Rodriguez M
AD  - SI2 Lab , Universidad de Las Americas , Quito 170504 , Ecuador.
FAU - Cruz-Monteagudo, Maykel
AU  - Cruz-Monteagudo M
AD  - Department of General Education , West Coast University , Miami Campus , Doral , 
      Florida 33178 , United States.
AD  - REQUIMTE/Departamento de Quimica e Bioquimica, Faculdade de Ciencias ,
      Universidade do Porto , Porto 4169-007 , Portugal.
AD  - CIQUP/Departamento de Quimica e Bioquimica, Facultade de Ciencias , Universidade 
      do Porto , Porto 4169-007 , Portugal.
FAU - Armijos-Jaramillo, Vinicio
AU  - Armijos-Jaramillo V
AD  - Bio-Cheminformatics Research Group and Facultad de Ingenieria y Ciencias
      Aplicadas , Universidad de Las Americas , Quito 170504 , Ecuador.
FAU - Cordeiro, M Natalia D S
AU  - Cordeiro MNDS
AUID- ORCID: 0000-0003-3375-8670
AD  - REQUIMTE/Departamento de Quimica e Bioquimica, Faculdade de Ciencias ,
      Universidade do Porto , Porto 4169-007 , Portugal.
FAU - Borges, Fernanda
AU  - Borges F
AUID- ORCID: 0000-0003-1050-2402
AD  - CIQUP/Departamento de Quimica e Bioquimica, Facultade de Ciencias , Universidade 
      do Porto , Porto 4169-007 , Portugal.
FAU - Sanchez-Rodriguez, Aminael
AU  - Sanchez-Rodriguez A
AD  - Departamento de Ciencias Biologicas , Universidad Tecnica Particular de Loja ,
      Loja 110107 , Ecuador.
FAU - Tejera, Eduardo
AU  - Tejera E
AD  - Bio-Cheminformatics Research Group and Facultad de Ingenieria y Ciencias
      Aplicadas , Universidad de Las Americas , Quito 170504 , Ecuador.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20190906
PL  - United States
TA  - J Chem Inf Model
JT  - Journal of chemical information and modeling
JID - 101230060
RN  - 0 (Ligands)
SB  - IM
MH  - Algorithms
MH  - Drug Design
MH  - Drug Discovery/*methods
MH  - Humans
MH  - Ligands
MH  - Molecular Docking Simulation
MH  - Protein Binding
MH  - *Software
MH  - Software Validation
EDAT- 2019/08/27 06:00
MHDA- 2020/09/12 06:00
CRDT- 2019/08/27 06:00
PHST- 2019/08/27 06:00 [pubmed]
PHST- 2020/09/12 06:00 [medline]
PHST- 2019/08/27 06:00 [entrez]
AID - 10.1021/acs.jcim.9b00343 [doi]
PST - ppublish
SO  - J Chem Inf Model. 2019 Sep 23;59(9):3655-3666. doi: 10.1021/acs.jcim.9b00343.
      Epub 2019 Sep 6.

PMID- 30513742
OWN - NLM
STAT- MEDLINE
DCOM- 20190211
LR  - 20200225
IS  - 1420-3049 (Electronic)
IS  - 1420-3049 (Linking)
VI  - 23
IP  - 12
DP  - 2018 Dec 1
TI  - Classical QSAR and Docking Simulation of 4-Pyridone Derivatives for Their
      Antimalarial Activity.
LID - E3166 [pii]
LID - 10.3390/molecules23123166 [doi]
AB  - In this work, the minimum energy structures of 22 4-pyridone derivatives have
      been optimized at Density Functional Theory level, and several quantum molecular,
      including electronic and thermodynamic descriptors, were computed for these
      substrates in order to obtain a statistical and meaningful QSAR equation. In this
      sense, by using multiple linear regressions, five mathematical models have been
      obtained. The best model with only four descriptors (r(2) = 0.86, Q(2) = 0.92,
      S.E.P = 0.38) was validated by the leave-one-out cross-validation method. The
      antimalarial activity can be explained by the combination of the four mentioned
      descriptors e.g., electronic potential, dipolar momentum, partition coefficient
      and molar refractivity. The statistical parameters of this model suggest that it 
      is robust enough to predict the antimalarial activity of new possible compounds; 
      consequently, three small chemical modifications into the structural core of
      these compounds were performed specifically on the most active compound of the
      series (compound 13). These three new suggested compounds were leveled as 13A,
      13B and 13C, and the predicted biological antimalarial activity is 0.02 microM,
      0.03 microM, and 0.07 microM, respectively. In order to complement these results 
      focused on the possible action mechanism of the substrates, a docking simulation 
      was included for these new structures as well as for the compound 13 and the
      docking scores (binding affinity) obtained for the interaction of these
      substrates with the cytochrome bc1, were -7.5, -7.2, -6.9 and -7.5 kcal/mol for
      13A, 13B, 13C and compound 13, respectively, which suggests that these compounds 
      are good candidates for its biological application in this illness.
FAU - Flores-Sumoza, Maryury
AU  - Flores-Sumoza M
AD  - Laboratorio de Fisicoquimica Organica y Quimica Computacional, Escuela de
      Ciencias, Departamento de Quimica, Universidad de Oriente, Barcelona 6001,
      Venezuela. maryuryfs@yahoo.com.
FAU - Alcazar, Jackson J
AU  - Alcazar JJ
AD  - Departamento de Quimica, Pontificia Universidad Catolica de Chile, Casilla 306,
      Santiago 6094411, Chile. jacksonalcazar@gmail.com.
FAU - Marquez, Edgar
AU  - Marquez E
AUID- ORCID: 0000-0002-7503-1528
AD  - Grupo de Investigaciones en Quimica y Biologia, Departamento de Quimica y
      Biologia, Facultad de Ciencias Exactas, Universidad del Norte, Carrera 51B, Km 5,
      via Puerto Colombia, Barranquilla 081007, Colombia. ebrazon@uninorte.edu.co.
FAU - Mora, Jose R
AU  - Mora JR
AUID- ORCID: 0000-0001-6128-9504
AD  - Grupo de Quimica computacional y teorica (QCT-USFQ) & instituto de Simulacion
      Computacional (ISC-USF) Colegio Politecnico de Ciencias e Ingenieria Diego de
      Robles, y Via Interoceanica, Universidad San Francisco de Quito, Quito 170901,
      Ecuador. jrmora@usfq.edu.ec.
FAU - Lezama, Jesus
AU  - Lezama J
AD  - Laboratorio de Fisicoquimica Organica y Quimica Computacional, Escuela de
      Ciencias, Departamento de Quimica, Universidad de Oriente, Barcelona 6001,
      Venezuela. jlezgar@gmail.com.
FAU - Puello, Esneyder
AU  - Puello E
AD  - Grupo de Investigacion en Oxi/Hidrotratamiento Catalitico y Nuevos Materiales,
      Programa de Quimica-Ciencias Basicas, Universidad del Atlantico, Barranquilla
      081001, Colombia. snypollqco@yahoo.com.
LA  - eng
PT  - Journal Article
DEP - 20181201
PL  - Switzerland
TA  - Molecules
JT  - Molecules (Basel, Switzerland)
JID - 100964009
RN  - 0 (Antimalarials)
RN  - 0 (Pyridones)
RN  - 3P2MV07G53 (4-pyridone)
SB  - IM
MH  - Algorithms
MH  - Antimalarials/*chemistry/*pharmacology
MH  - Inhibitory Concentration 50
MH  - *Molecular Docking Simulation
MH  - *Molecular Dynamics Simulation
MH  - Molecular Structure
MH  - Parasitic Sensitivity Tests
MH  - Pyridones/*chemistry/*pharmacology
MH  - *Quantitative Structure-Activity Relationship
PMC - PMC6321536
OTO - NOTNLM
OT  - DFT
OT  - computational study
OT  - molecular descriptors
OT  - nitrogen compounds
EDAT- 2018/12/06 06:00
MHDA- 2019/02/12 06:00
CRDT- 2018/12/06 06:00
PHST- 2018/10/13 00:00 [received]
PHST- 2018/11/21 00:00 [revised]
PHST- 2018/11/22 00:00 [accepted]
PHST- 2018/12/06 06:00 [entrez]
PHST- 2018/12/06 06:00 [pubmed]
PHST- 2019/02/12 06:00 [medline]
AID - molecules23123166 [pii]
AID - 10.3390/molecules23123166 [doi]
PST - epublish
SO  - Molecules. 2018 Dec 1;23(12). pii: molecules23123166. doi:
      10.3390/molecules23123166.

PMID- 28067172
OWN - NLM
STAT- MEDLINE
DCOM- 20180716
LR  - 20181113
IS  - 1875-6190 (Electronic)
IS  - 1570-159X (Linking)
VI  - 15
IP  - 8
DP  - 2017 Nov 14
TI  - Fusing Docking Scoring Functions Improves the Virtual Screening Performance for
      Discovering Parkinson&#39;s Disease Dual Target Ligands.
PG  - 1107-1116
LID - 10.2174/1570159X15666170109143757 [doi]
AB  - BACKGROUND: Virtual methodologies have become essential components of the drug
      discovery pipeline. Specifically, structure-based drug design methodologies
      exploit the 3D structure of molecular targets to discover new drug candidates
      through molecular docking. Recently, dual target ligands of the Adenosine A2A
      Receptor and Monoamine Oxidase B enzyme have been proposed as effective therapies
      for the treatment of Parkinson's disease. METHODS: In this paper we propose a
      structure-based methodology, which is extensively validated, for the discovery of
      dual Adenosine A2A Receptor/Monoamine Oxidase B ligands. This methodology
      involves molecular docking studies against both receptors and the evaluation of
      different scoring functions fusion strategies for maximizing the initial virtual 
      screening enrichment of known dual ligands. RESULTS: The developed methodology
      provides high values of enrichment of known ligands, which outperform that of the
      individual scoring functions. At the same time, the obtained ensemble can be
      translated in a sequence of steps that should be followed to maximize the
      enrichment of dual target Adenosine A2A Receptor antagonists and Monoamine
      Oxidase B inhibitors. CONCLUSION: Information relative to docking scores to both 
      targets have to be combined for achieving high dual ligands enrichment. Combining
      the rankings derived from different scoring functions proved to be a valuable
      strategy for improving the enrichment relative to single scoring function in
      virtual screening experiments.
CI  - Copyright(c) Bentham Science Publishers; For any queries, please email at
      epub@benthamscience.org.
FAU - Perez-Castillo, Yunierkis
AU  - Perez-Castillo Y
AD  - Seccion Fisico Quimica y Matematicas, Departamento de Quimica, Universidad
      Tecnica Particular de Loja, San Cayetano Alto S/N, EC1101608 Loja, Ecuador.
AD  - Molecular Simulation and Drug Design Group, Centro de Bioactivos Quimicos (CBQ), 
      Universidad Central "Marta Abreu" de Las Villas, Santa Clara, 54830, Cuba.
FAU - Helguera, Aliuska Morales
AU  - Helguera AM
AD  - Molecular Simulation and Drug Design Group, Centro de Bioactivos Quimicos (CBQ), 
      Universidad Central "Marta Abreu" de Las Villas, Santa Clara, 54830, Cuba.
FAU - Cordeiro, M Natalia D S
AU  - Cordeiro MNDS
AD  - REQUIMTE, Department of Chemistry and Biochemistry, Faculty of Sciences,
      University of Porto, 4169-007 Porto, Portugal.
FAU - Tejera, Eduardo
AU  - Tejera E
AD  - Instituto de Investigaciones Biomedicas (IIB), Universidad de Las Americas,
      170513 Quito, Ecuador.
FAU - Paz-Y-Mino, Cesar
AU  - Paz-Y-Mino C
AD  - Instituto de Investigaciones Biomedicas (IIB), Universidad de Las Americas,
      170513 Quito, Ecuador.
FAU - Sanchez-Rodriguez, Aminael
AU  - Sanchez-Rodriguez A
AD  - Departamento de Ciencias Naturales, Universidad Tecnica Particular de Loja, Calle
      Paris S/N, EC1101608 Loja, Ecuador.
FAU - Borges, Fernanda
AU  - Borges F
AD  - CIQUP/Departamento de Quimica e Bioquimica, Faculdade de Ciencias, Universidade
      do Porto, Porto 4169-007, Portugal.
FAU - Cruz-Monteagudo, Maykel
AU  - Cruz-Monteagudo M
AD  - Instituto de Investigaciones Biomedicas (IIB), Universidad de Las Americas,
      170513 Quito, Ecuador.
AD  - CIQUP/Departamento de Quimica e Bioquimica, Faculdade de Ciencias, Universidade
      do Porto, Porto 4169-007, Portugal.
LA  - eng
PT  - Journal Article
PL  - United Arab Emirates
TA  - Curr Neuropharmacol
JT  - Current neuropharmacology
JID - 101157239
RN  - 0 (Adenosine A2 Receptor Antagonists)
RN  - 0 (Ligands)
RN  - 0 (Monoamine Oxidase Inhibitors)
RN  - 0 (Receptor, Adenosine A2A)
RN  - EC 1.4.3.4 (Monoamine Oxidase)
SB  - IM
MH  - Adenosine A2 Receptor Antagonists/chemistry/*therapeutic use
MH  - Animals
MH  - Binding Sites/drug effects
MH  - Humans
MH  - Ligands
MH  - *Molecular Docking Simulation
MH  - Monoamine Oxidase/*metabolism
MH  - Monoamine Oxidase Inhibitors/chemistry/*therapeutic use
MH  - Parkinson Disease/*drug therapy
MH  - Protein Binding/drug effects
MH  - Receptor, Adenosine A2A/*metabolism
MH  - Structure-Activity Relationship
MH  - User-Computer Interface
PMC - PMC5725543
OTO - NOTNLM
OT  - Parkinson's disease
OT  - dual target ligands
OT  - molecular docking
OT  - scoring fusion.
EDAT- 2017/01/10 06:00
MHDA- 2018/07/17 06:00
CRDT- 2017/01/10 06:00
PHST- 2015/10/11 00:00 [received]
PHST- 2016/01/18 00:00 [revised]
PHST- 2016/11/03 00:00 [accepted]
PHST- 2017/01/10 06:00 [pubmed]
PHST- 2018/07/17 06:00 [medline]
PHST- 2017/01/10 06:00 [entrez]
AID - 10.2174/1570159X15666170109143757 [doi]
AID - CN-EPUB-80907 [pii]
PST - ppublish
SO  - Curr Neuropharmacol. 2017 Nov 14;15(8):1107-1116. doi:
      10.2174/1570159X15666170109143757.

PMID- 26355653
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20171116
IS  - 1549-960X (Electronic)
IS  - 1549-9596 (Linking)
VI  - 55
IP  - 10
DP  - 2015 Oct 26
TI  - Harmonization of QSAR Best Practices and Molecular Docking Provides an Efficient 
      Virtual Screening Tool for Discovering New G-Quadruplex Ligands.
PG  - 2094-110
LID - 10.1021/acs.jcim.5b00415 [doi]
AB  - Telomeres and telomerase are key players in tumorogenesis. Among the various
      strategies proposed for telomerase inhibition or telomere uncapping, the
      stabilization of telomeric G-quadruplex (G4) structures is a very promising one. 
      Additionally, G4 stabilizing ligands also act over tumors mediated by the
      alternative elongation of telomeres. Accordingly, the discovery of novel
      compounds able to act on telomeres and/or inhibit the telomerase enzyme by
      stabilizing DNA telomeric G4 structures as well as the development of approaches 
      efficiently prioritizing such compounds constitute active areas of research in
      computational medicinal chemistry and anticancer drug discovery. In this
      direction, we applied a virtual screening strategy based on the rigorous
      application of QSAR best practices and its harmonized integration with
      structure-based methods. More than 600,000 compounds from commercial databases
      were screened, the first 99 compounds were prioritized, and 21 commercially
      available and structurally diverse candidates were purchased and submitted to
      experimental assays. Such strategy proved to be highly efficient in the
      prioritization of G4 stabilizer hits, with a hit rate of 23.5%. The best G4
      stabilizer hit found exhibited a shift in melting temperature from FRET assay of 
      +7.3 degrees C at 5 muM, while three other candidates also exhibited a promising 
      stabilizing profile. The two most promising candidates also exhibited a good
      telomerase inhibitory ability and a mild inhibition of HeLa cells growth. None of
      these candidates showed antiproliferative effects in normal fibroblasts. Finally,
      the proposed virtual screening strategy proved to be a practical and reliable
      tool for the discovery of novel G4 ligands which can be used as starting points
      of further optimization campaigns.
FAU - Castillo-Gonzalez, Daimel
AU  - Castillo-Gonzalez D
AD  - ARNA Laboratory, IECB, University of Bordeaux , F-33600 Pessac, France.
AD  - ARNA Laboratory, INSERM, U869, F-33000 Bordeaux, France.
FAU - Mergny, Jean-Louis
AU  - Mergny JL
AD  - ARNA Laboratory, IECB, University of Bordeaux , F-33600 Pessac, France.
AD  - ARNA Laboratory, INSERM, U869, F-33000 Bordeaux, France.
FAU - De Rache, Aurore
AU  - De Rache A
AD  - ARNA Laboratory, IECB, University of Bordeaux , F-33600 Pessac, France.
AD  - ARNA Laboratory, INSERM, U869, F-33000 Bordeaux, France.
FAU - Perez-Machado, Gisselle
AU  - Perez-Machado G
AD  - Molecular Simulation and Drug Design Group, Centro de Bioactivos Quimicos (CBQ), 
      Central University of Las Villas , Santa Clara, Villa Clara 54830, Cuba.
AD  - Department of Physiology, Faculty of Medicine, University of Valencia , Valencia 
      46010, Valencia, Spain.
AD  - Department of Pharmacy and Pharmaceutical Technology, University of Valencia ,
      Burjassot 46100, Valencia, Spain.
FAU - Cabrera-Perez, Miguel Angel
AU  - Cabrera-Perez MA
AD  - Molecular Simulation and Drug Design Group, Centro de Bioactivos Quimicos (CBQ), 
      Central University of Las Villas , Santa Clara, Villa Clara 54830, Cuba.
AD  - Department of Pharmacy and Pharmaceutical Technology, University of Valencia ,
      Burjassot 46100, Valencia, Spain.
AD  - Department of Engineering, Area of Pharmacy and Pharmaceutical Technology, Miguel
      Hernandez University , 03550 Sant Joan d'Alacant, Alicante, Alicante, Spain.
FAU - Nicolotti, Orazio
AU  - Nicolotti O
AD  - Dipartimento di Farmacia-Scienze, Universita degli Studi di Bari "Aldo Moro'' ,
      Via Orabona 4, 70125 Bari, Bari, Italy.
FAU - Introcaso, Antonellina
AU  - Introcaso A
AD  - Dipartimento di Farmacia-Scienze, Universita degli Studi di Bari "Aldo Moro'' ,
      Via Orabona 4, 70125 Bari, Bari, Italy.
FAU - Mangiatordi, Giuseppe Felice
AU  - Mangiatordi GF
AD  - Dipartimento di Farmacia-Scienze, Universita degli Studi di Bari "Aldo Moro'' ,
      Via Orabona 4, 70125 Bari, Bari, Italy.
FAU - Guedin, Aurore
AU  - Guedin A
AD  - ARNA Laboratory, IECB, University of Bordeaux , F-33600 Pessac, France.
AD  - ARNA Laboratory, INSERM, U869, F-33000 Bordeaux, France.
FAU - Bourdoncle, Anne
AU  - Bourdoncle A
AD  - ARNA Laboratory, IECB, University of Bordeaux , F-33600 Pessac, France.
AD  - ARNA Laboratory, INSERM, U869, F-33000 Bordeaux, France.
FAU - Garrigues, Teresa
AU  - Garrigues T
AD  - Department of Pharmacy and Pharmaceutical Technology, University of Valencia ,
      Burjassot 46100, Valencia, Spain.
FAU - Pallardo, Federico
AU  - Pallardo F
AD  - Department of Physiology, Faculty of Medicine, University of Valencia , Valencia 
      46010, Valencia, Spain.
FAU - Cordeiro, M Natalia D S
AU  - Cordeiro MN
FAU - Paz-Y-Mino, Cesar
AU  - Paz-Y-Mino C
AD  - Instituto de Investigaciones Biomedicas (IIB), Universidad de Las Americas ,
      170513 Quito, Pichincha, Ecuador.
FAU - Tejera, Eduardo
AU  - Tejera E
AD  - Instituto de Investigaciones Biomedicas (IIB), Universidad de Las Americas ,
      170513 Quito, Pichincha, Ecuador.
FAU - Borges, Fernanda
AU  - Borges F
FAU - Cruz-Monteagudo, Maykel
AU  - Cruz-Monteagudo M
AD  - Instituto de Investigaciones Biomedicas (IIB), Universidad de Las Americas ,
      170513 Quito, Pichincha, Ecuador.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150918
PL  - United States
TA  - J Chem Inf Model
JT  - Journal of chemical information and modeling
JID - 101230060
RN  - 0 (Acridines)
RN  - 0 (Ligands)
RN  - Z7C5CD91WI (BRACO-19)
SB  - IM
MH  - Acridines/*chemistry
MH  - Cell Proliferation
MH  - Crystallography, X-Ray
MH  - Drug Discovery
MH  - *Drug Evaluation, Preclinical
MH  - Fibroblasts/chemistry
MH  - *G-Quadruplexes
MH  - HeLa Cells
MH  - Humans
MH  - Ligands
MH  - *Molecular Docking Simulation
MH  - Molecular Structure
MH  - Quantitative Structure-Activity Relationship
MH  - Telomere/chemistry
EDAT- 2015/09/12 06:00
MHDA- 2016/08/24 06:00
CRDT- 2015/09/11 06:00
PHST- 2015/09/11 06:00 [entrez]
PHST- 2015/09/12 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - 10.1021/acs.jcim.5b00415 [doi]
PST - ppublish
SO  - J Chem Inf Model. 2015 Oct 26;55(10):2094-110. doi: 10.1021/acs.jcim.5b00415.
      Epub 2015 Sep 18.
